This week, vaccine manufacturer Moderna revealed that Vinaya Prasad, the top vaccine regulator at the Food and Drug Administration (FDA)—which is a part of HHS— declined to even consider the safety ...
In a breakthrough in cancer treatment, Russia’s cancer vaccine has completed preclinical trials demonstrating both safety and high efficacy., Veronika Skvortsova, head of the Federal Medical and ...
Oct 22 (Reuters) - Cancer patients who received mRNA-based COVID vaccines within 100 days of starting treatment with widely used immunotherapies were twice as likely to be alive three years after ...
The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be ...
America’s drug safety agency declined to review a next-gen flu vaccine that uses the same tech as the coronavirus shots ...
The FDA declined to review Moderna's mRNA influenza vaccine due to inadequate clinical trial comparators for older adults.
The U.S. Food and Drug Administration (FDA) said it will not review Moderna’s application for the first mRNA-based flu shot.
Oklahoma has always valued independence, common sense and practical solutions. mRNA therapeutics help doctors do no harm and ...